List of Biotech, Pharmaceutical & Life Sciences companies in Greece - 5

BIOPIX-T is a certified MedTech Company, compliant with ISO 13485:2016 & 27001:2013 standards, specializing in the design, development, production, storage, and distribution of molecular diagnostic devices and nucleic acid amplification kits for point-of-care applications. Our focus is on healthcare-diagnostics markets, offering instruments and standardized assays for pathogen detection and monitoring in Human (Infectious Diseases and Companion Diagnostics), Food, Plant, Veterinary, and Environmental samples. Our mission is to make BIOPIX-T's diagnostic solutions accessible on the front lines of healthcare, enabling lab-quality testing anytime, anywhere. Join us in revolutionizing healthcare diagnostics!

Democritus University of Thrace is an academic institution that provides higher education services.

Reproducible -omics data interpretation, i.e. the derivation of actionable molecular biomarkers, is currently the main bottleneck in streamlined applications, obstructing the transformation of genomic information into insights for Biomedicine and Biotech. BioInfoMiner delivers unsupervized, fast and integrative interpretation of -omics experiments, in the form of biomarker signatures. Prioritized genes are mapped to few, clear, systemic pathways and phenotypes, enabling seamless biomarker identification and prioritization.

Purposeful aims to discover alternative effects for existing drugs using its advanced computational workflow that combines Artificial Intelligence, Data Analytics and Smart Filtering. Our mission is to solve the high cost of drug development by using our intelligent drug repurposing computational methodology and thus contribute to relieving a group of people which have been traditionally overlooked.

ResQ Biotech is a spin-off company of the National Hellenic Research Foundation (NHRF), which was founded in 2019 and is based in the Patras Science Park, Greece. The main activity of the company consists in the discovery, preclinical development and commercial exploitation of potentially therapeutic molecules against diseases caused by problematic protein folding, such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. The creation of ResQ Biotech has been based on the high level of expertise developed in the laboratory of Dr. Georgios Skretas at the Institute of Chemical Biology of the NHRF, which concerns the use of biotechnological methods for the discovery of these molecules by applying an innovative synthetic biotechnology methodology. Additionally, the company has extensive experience in the biosynthetic production of difficult proteins, such as human membrane proteins, for further study and characterization. ResQ Biotech's long-standing experience of pre-clinical development and commercial exploitation of scientific research allows for the successful completion of the early stages of the discovery and development of new drugs against these diseases.